Chemoinformaics analysis of ENT-15BETA,16-EPOXY-KAURAN-17-OL
| Molecular Weight | 304.474 | nRot | 1 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 21 |
| Exact Molecular Weight | 304.24 | nRing | 5 |
| Solubility: LogS | -5.323 | nHRing | 1 |
| Solubility: LogP | 4.677 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 56.3414 |
| nHD | 1 | BPOL | 33.8386 |
| QED | 0.738 |
| Synth | 5.882 |
| Natural Product Likeliness | 3.602 |
| NR-PPAR-gamma | 0.061 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.081 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.938 |
| MDCK | 0.0000246 |
| BBB | 0.678 |
| PPB | 0.959834 |
| VDSS | 1.554 |
| FU | 0.0364928 |
| CYP1A2-inh | 0.058 |
| CYP1A2-sub | 0.652 |
| CYP2c19-inh | 0.055 |
| CYP2c19-sub | 0.918 |
| CYP2c9-inh | 0.269 |
| CYP2c9-sub | 0.224 |
| CYP2d6-inh | 0.037 |
| CYP2d6-sub | 0.863 |
| CYP3a4-inh | 0.335 |
| CYP3a4-sub | 0.183 |
| CL | 13.34 |
| T12 | 0.08 |
| hERG | 0.01 |
| Ames | 0.034 |
| ROA | 0.085 |
| SkinSen | 0.169 |
| Carcinogencity | 0.082 |
| EI | 0.82 |
| Respiratory | 0.959 |
| NR-Aromatase | 0.833 |
| Antiviral | No |
| Prediction | 0.73418 |